Dr. Rosas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7200 Cambridge St
Houston, TX 77030Phone+1 713-798-2400Fax+1 713-798-2688- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1995 - 1998
- Brooklyn Hospital CenterInternship, Internal Medicine, 1994 - 1995
- National University of ColombiaClass of 1991
Certifications & Licensure
- TX State Medical License 2019 - 2024
- MA State Medical License 2008 - 2021
- MD State Medical License 1997 - 2013
- PA State Medical License 2005 - 2008
- DC State Medical License 2004 - 2008
Clinical Trials
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study.Choi, B., Liu, G., Sheng, Q., Amancherla, K., Perry, A., Huang, X., San José Estépar, R., Ash, S., Guan, W., Jacobs, D., Martinez, F., Rosas, I., Bowler, R., Kropski, ...> ;American Journal of Respiratory and Critical Care Medicine. 2024 Jan 29
- Spatial Transcriptomics Resolve an Emphysema-Specific Lymphoid Follicle B Cell Signature in Chronic Obstructive Pulmonary Disease.Joselyn Rojas-Quintero, Scott A Ochsner, Felicia New, Prajan Divakar, Chen Xi Yang, Tianshi David Wu, Jerid Robinson, Darshan Shimoga Chandrashekar, Nicholas E Banovic...> ;American Journal of Respiratory and Critical Care Medicine. 2024 Jan 1
- TRIOBP modulates β-catenin signaling by regulation of miR-29b in idiopathic pulmonary fibrosis.Wang, L., Zhao, W., Xia, C., Ma, S., Li, Z., Wang, N., Ding, L., Wang, Y., Cheng, L., Liu, H., Yang, J., Li, Y., Yu, G., Rosas, I.> ;Cellular and Molecular Life Sciences. 2023 Dec 29
- Join now to see all
Journal Articles
- Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaIvan O Rosas, Ronaldo C Go, Ivor S Douglas, Larry Tsai, Atul Malhotra, The New England Journal of Medicine
- MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseaseJay H Ryu, Deborah Assayag, Marvin I Schwarz, Paul Wolters, Andrew Gross, Ivan O Rosas, The New England Journal of Medicine
Press Mentions
- Digital Atlas Created for Chronic Lung DiseaseJuly 8th, 2020
- All the Ways Doctors Are Treating Coronavirus Right NowJune 23rd, 2020
- Devastating Disease of the Lung Is a New Research Gift’s FocusJuly 16th, 2018
- Join now to see all
Grant Support
- Syndecan-2 And Clinical Progression Of Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2009–2012
- Syndecan-2 And Clinical Progression Of Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2008
Hospital Affiliations
- St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: